Aaron Scott, of Fayetteville, is the first in North Carolina to receive a new FDA-approved therapy which uses the patient's own cells to relieve the pain of sickle cell disease.
With spring break quickly approaching, let’s take a look at some breaking scientific discoveries and news, from a new sickle ...
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Acquired DNA mutations found in the SERPINA1 gene can protect liver cells from damage in patients with alpha-1 antitrypsin ...
ROCHESTER, N.Y. – Researchers at Golisano Children’s Hospital have received a multi-million-dollar grant to lead a ...
Comic Book Resources on MSN1d
Watson Season 1, Episode 5 Shows The Heartlessness of HealthcareThis episode highlights how Watson's medical format can address real-world issues in dramatically interesting ways, with a ...
New research from RCSI University of Medicine and Health Sciences has found that white blood cells which 'remember' past ...
Beam Therapeutics reports Phase 1/2 trial data showing BEAM-302's potential in AATD treatment, with dose-dependent mutation correction and sustained effects.
Former Miss Universe Ireland Aishah Akorede and her pro dance partner Robert Rowinski were last night voted off RTÉ’s Dancing ...
Explore the benefits of adopting universal molecular genetic testing for newborn screening of haemoglobinopathies to improve ...
Recent headlines in the U.K. lauded the approval of a new sickle cell cure using gene-editing technology. Columnist Mary Shaniqua has doubts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback